Limitations on Development. After the Signing Date and during the Term, neither Party nor any of its Affiliates shall, directly or through any Third Party, sponsor, conduct or cause to be conducted, otherwise assist in, or supply any Collaboration Product for use in connection with, or otherwise fund, any Clinical Trial of any Collaboration Product outside of the Development Plan, without the prior written consent of the other Party.
Appears in 4 contracts
Samples: Collaboration and License Agreement (Facet Biotech Corp), Collaboration and License Agreement (Trubion Pharmaceuticals, Inc), Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)
Limitations on Development. After the Signing Effective Date and during the Termterm of this Agreement, neither Party nor any of its Affiliates shall, directly or through any Third Party, sponsor, conduct or cause to be conducted, otherwise assist in, or supply any Collaboration Product for use in connection with, or otherwise fund, any Clinical Trial clinical trial or clinical study of any Collaboration Product outside of the Global Development Plan or any Annual Development Plan, without the prior written consent of the other Party.
Appears in 4 contracts
Samples: Collaboration Agreement (Exelixis Inc), Collaboration Agreement (Facet Biotech Corp), Collaboration Agreement (PDL Biopharma, Inc.)
Limitations on Development. After During the Signing Date and during the Termterm of this Agreement, neither Party nor any of its Affiliates shall, directly or through any Third Party, sponsor, conduct or cause to be conducted, otherwise assist in, or supply any Collaboration Co-Developed Product (or an XL281 Product in the case of Exelixis) for use in connection with, or otherwise fund, any Clinical Trial clinical trial or clinical study of any Collaboration such Product outside of the Global Development Plan or any Annual Development Plan, without the prior written consent of the other Party.
Appears in 1 contract
